Yirui Cheng

859 total citations
15 papers, 407 citations indexed

About

Yirui Cheng is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Yirui Cheng has authored 15 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Pharmacology. Recurrent topics in Yirui Cheng's work include Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (3 papers) and Fibroblast Growth Factor Research (2 papers). Yirui Cheng is often cited by papers focused on Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (3 papers) and Fibroblast Growth Factor Research (2 papers). Yirui Cheng collaborates with scholars based in China, Sweden and Hong Kong. Yirui Cheng's co-authors include Weiliang Xia, Qing Han, Tingyu Wu, Shun Lü, Qingyu Zeng, Ziming Li, Yanshuang Zhang, Wenxiang Ji, Shan He and Yongfeng Yu and has published in prestigious journals such as Cancer Research, Oncogene and Journal of Agricultural and Food Chemistry.

In The Last Decade

Yirui Cheng

15 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yirui Cheng China	9	305	192	52	44	33	15	407
Quanyi Lu China	11	270 0.9×	117 0.6×	69 1.3×	19 0.4×	25 0.8×	52	425
Yanan Pi China	8	191 0.6×	90 0.5×	63 1.2×	47 1.1×	51 1.5×	13	357
Xueping Han China	7	309 1.0×	181 0.9×	81 1.6×	40 0.9×	18 0.5×	16	473
Yonghong Guo China	8	219 0.7×	181 0.9×	57 1.1×	22 0.5×	24 0.7×	15	389
Ali Mahdavinezhad Iran	12	268 0.9×	215 1.1×	55 1.1×	25 0.6×	10 0.3×	33	427
Chungen Xing China	10	300 1.0×	274 1.4×	65 1.3×	24 0.5×	19 0.6×	30	459
Jipeng Wang China	11	214 0.7×	137 0.7×	30 0.6×	42 1.0×	14 0.4×	17	304
Peri Nagappan United States	10	215 0.7×	91 0.5×	70 1.3×	50 1.1×	19 0.6×	14	378
Fengxiang Pang China	11	214 0.7×	91 0.5×	68 1.3×	21 0.5×	44 1.3×	19	385
Aferin Beilerli Russia	13	249 0.8×	202 1.1×	16 0.3×	22 0.5×	34 1.0×	33	435

Countries citing papers authored by Yirui Cheng

Since Specialization

Citations

This map shows the geographic impact of Yirui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yirui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yirui Cheng more than expected).

Fields of papers citing papers by Yirui Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yirui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yirui Cheng. The network helps show where Yirui Cheng may publish in the future.

Co-authorship network of co-authors of Yirui Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yirui Cheng. A scholar is included among the top collaborators of Yirui Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yirui Cheng. Yirui Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lü, Xin, Zhuang Yu, Tingyu Wu, et al.. (2024). The unexpected PD-L1 suppression function of celery-derived extracellular vesicles improves lung cancer chemotherapy efficacy. PubMed. 5(4). 697–713. 8 indexed citations

Wu, Tingyu, Yanshuang Zhang, Qing Han, et al.. (2023). Klotho-beta attenuates Rab8a-mediated exosome regulation and promotes prostate cancer progression. Oncogene. 42(38). 2801–2815. 4 indexed citations

Yao, Jing, et al.. (2023). Effect of deep eutectic solvent extraction on Auricularia auricula polysaccharide solubilization and antioxidant potential. Sustainable Chemistry and Pharmacy. 34. 101166–101166. 22 indexed citations

Yao, Jing, et al.. (2023). Effects of the Extraction Solvents on Dissolution Rate and Antioxidant Capacity of Auricularia auricula (Agaricomycetes) Polysaccharides In Vitro and In Vivo. International journal of medicinal mushrooms. 25(5). 61–74. 4 indexed citations

Yao, Jing, et al.. (2023). Preparation of Auricularia auricula polysaccharides and their protective effect on acute oxidative stress injury of Caenorhabditis elegans. International Journal of Biological Macromolecules. 253(Pt 8). 127427–127427. 12 indexed citations

Lü, Xin, Qing Han, Jiachen Chen, et al.. (2023). Celery (Apium graveolens L.) Exosome-like Nanovesicles as a New-Generation Chemotherapy Drug Delivery Platform against Tumor Proliferation. Journal of Agricultural and Food Chemistry. 71(22). 8413–8424. 56 indexed citations

Cheng, Yirui, Xin Lü, Fan Li, et al.. (2022). NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation. Protein & Cell. 14(2). 123–136. 6 indexed citations

Zhang, Yanshuang, Tingyu Wu, Fan Li, et al.. (2022). FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy. Frontiers in Oncology. 12. 846744–846744. 5 indexed citations

Wang, Yuting, Xiaomin Niu, Yirui Cheng, et al.. (2022). Exosomal PD-L1 predicts response with immunotherapy in NSCLC patients. Clinical & Experimental Immunology. 208(3). 316–322. 29 indexed citations

10.

Han, Qing, Charles Xie, Fan Li, et al.. (2021). Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer. Theranostics. 11(13). 6526–6541. 103 indexed citations

11.

Han, Qing, Qian Xie, Fan Li, et al.. (2021). Abstract 1152: Targeted inhibition of SIRT6 by engineered exosomes suppressed tumorigenesis and metastasis in prostate cancer. Cancer Research. 81(13_Supplement). 1152–1152. 1 indexed citations

12.

Li, Fan, Ziming Li, Qing Han, et al.. (2020). Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104. Oncogene. 39(17). 3507–3521. 30 indexed citations

13.

Cheng, Yirui, Qingyu Zeng, Ruochen Li, et al.. (2020). Comparison of serum exosome isolation methods on co-precipitated free microRNAs. PeerJ. 8. e9434–e9434. 20 indexed citations

14.

Zeng, Qingyu, et al.. (2019). Regulation of exosomes secretion by low-intensity pulsed ultrasound in lung cancer cells. Experimental Cell Research. 383(1). 111448–111448. 14 indexed citations

15.

He, Shan, Ziming Li, Yongfeng Yu, et al.. (2019). Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma. Experimental Cell Research. 379(2). 203–213. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact